Chu D - Search Results

1

[Primary result of the efficacy and tolerance of gefitinib in advanced non-small cell lung cancer patients with brain metastasis].

Wang Y, Wang Y, Wang B, Wang Z, Zhang X, Chu D, Sun Y. Wang Y, et al. Among authors: chu d. Zhongguo Fei Ai Za Zhi. 2006 Oct 20;9(5):447-51. doi: 10.3779/j.issn.1009-3419.2006.05.12. Zhongguo Fei Ai Za Zhi. 2006. PMID: 21176469 Free article. Chinese.

2

[Clinic outcome of gefitinib in sixty-nine elderly patients with lung adenocarcinoma.].

Wang Y, Zhang X, Wang B, Wang Z, Chu D, Sun Y. Wang Y, et al. Among authors: chu d. Zhongguo Fei Ai Za Zhi. 2008 Feb 20;11(1):137-41. doi: 10.3779/j.issn.1009-3419.2008.01.029. Zhongguo Fei Ai Za Zhi. 2008. PMID: 20727283 Free article. Chinese.

3

[Iressa in the treatment of 24 cases of advanced non-small cell lung cancer patients who had failed to previous chemotherapy].

Lin L, Wang B, Zhang X, Chu D. Lin L, et al. Among authors: chu d. Zhongguo Fei Ai Za Zhi. 2006 Jun 20;9(3):280-2. doi: 10.3779/j.issn.1009-3419.2006.03.16. Zhongguo Fei Ai Za Zhi. 2006. PMID: 21172163 Free article. Chinese.

4

[IRESSA in the treatment of advanced non-small-cell lung cancer patients who failed to respond previous chemotherapy].

Wang B, Zhang XR, Chu DT. Wang B, et al. Zhonghua Zhong Liu Za Zhi. 2004 Dec;26(12):742-5. Zhonghua Zhong Liu Za Zhi. 2004. PMID: 15733394 Chinese.

5

[Gefitinib in the treatment of male patients with advanced non-small-cell lung cancer].

Wang B, Zhang XR, Chu DT. Wang B, et al. Zhonghua Zhong Liu Za Zhi. 2007 Jul;29(7):549-51. Zhonghua Zhong Liu Za Zhi. 2007. PMID: 18069641 Chinese.

6

[Sequential administration of gefitinib and docetaxel as second-line therapy for advanced non-small cell lung cancer: analysis of 82 cases].

Wang Y, Zhang XR, Wang HJ, Wang B, Chu DT, Sun Y. Wang Y, et al. Zhonghua Yi Xue Za Zhi. 2008 Aug 19;88(32):2258-62. Zhonghua Yi Xue Za Zhi. 2008. PMID: 19087674 Chinese.

7

Polymorphisms of EGFR predict clinical outcome in advanced non-small-cell lung cancer patients treated with Gefitinib.

Ma F, Sun T, Shi Y, Yu D, Tan W, Yang M, Wu C, Chu D, Sun Y, Xu B, Lin D. Ma F, et al. Among authors: chu d. Lung Cancer. 2009 Oct;66(1):114-9. doi: 10.1016/j.lungcan.2008.12.025. Epub 2009 Feb 6. Lung Cancer. 2009. PMID: 19201048

8

The treatment of advanced non-small-cell lung cancer (NSCLC)--overseas updated and local experiences.

Chu DT, Zhang XR, Li JL, Qu FL, Sun Y. Chu DT, et al. Gan To Kagaku Ryoho. 2002 Feb;29 Suppl 1:117-24. Gan To Kagaku Ryoho. 2002. PMID: 11890097 Review. No abstract available.

9

[Phase II study of paclitaxel and cisplatin for advanced squamous-cell carcinoma of esophagus].

Huang J, Cai RG, Meng PJ, Zhang MJ, Cui CX, Yang L, Chu DT, Sun Y, Wang JW. Huang J, et al. Zhonghua Zhong Liu Za Zhi. 2004 Dec;26(12):753-5. Zhonghua Zhong Liu Za Zhi. 2004. PMID: 15733398 Clinical Trial. Chinese.

10

[A randomized trial comparing oxaliplatin plus vinorelbine versus cisplatin plus vinorelbine for the treatment of patients with advanced non-small-cell lung cancer].

Zhang XR, Hou M, Sun JD, Gao JF, Zhu YZ, Peng DW, Zhang YP, Chen J, Yang JL, Liang J, Wang PH, Chu DT. Zhang XR, et al. Zhonghua Zhong Liu Za Zhi. 2005 Dec;27(12):743-6. Zhonghua Zhong Liu Za Zhi. 2005. PMID: 16483488 Clinical Trial. Chinese.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

2,664 results

Search Page

Filters